- 2013
-
What's on? - 09.04.2013
Parkinson’s disease: can the brain be regenerated?
Parkinson’s disease Day was held on 12 April; about 100,000 people in France suffer from it. Parkinson’s disease was described for the first time by James Parkinson in 1817; it is a degenerative condition, often of unknown origin. The disease mainly affects people aged over 60. The first symptoms for diagnosing the illness are a […]
-
Press releases - 05.04.2013
Is the mother’s immune system capable of protecting the foetus from cytomegalovirus infection?
An infection from the cytomegalovirus (CMV), a virus belong to the herpesviridae family, usually goes unnoticed in a healthy subject, but in pregnant women, it can be harmful to the foetus.
-
Press releases - 04.04.2013
The health of 30 000 students to be monitored over 10 years
The i-Share study, the only one of its type in the world, intends to monitor the state of health of 30 000 students over a period of 10 years. It will provide precious information on the state of health of students, to ensure better management of the health system for this population. This cohort study is being carried out by Inserm, the Université de Versailles Saint-Quentin-en-Yvelines and the Université de Bordeaux
-
Press releases - 03.04.2013
(French) Les enfants de la cohorte Elfe fêtent déjà leur deuxième anniversaire !
Le deuxième anniversaire des premiers bébés, en ce début avril, est l’occasion pour les équipes de l’étude d’établir un bilan d’étape et de présenter les prochaines échéances. Les premiers résultats seront communiqués en 2014.
-
Press releases - 02.04.2013
Producing new neurones under all circumstances: a challenge that is just a mouse away ….
INSERM and CEA researchers recently showed that the pharmacological blocking of the TGFβ molecule improves the production of new neurones in the mouse model.
-
News in brief - 02.04.2013
Genetic involvement in epilepsy?
A gene involved in so-called “focal” epilepsy, the most frequent form of the condition, has been discovered by the research team directed by Eric Leguern and Stéphanie Baulac of Inserm unit 975 “Genetics and physiopathology of family epilepsy” at the Institut du Cerveau et de la Moelle (ICM) of the Pitié-Salpêtrière Hospital. The researchers studied […]
-
What's on? - 27.03.2013
Publication of the Food Nutritional Composition Table
The table was published by Editions ECONOMICA, through scientific coordination with the NutriNet-Santé and presents the current data concerning the nutritional composition table of food used in the context of the NutriNet-Santé study. Launched in France in May 2009, this study of a prospective observation cohort (www.etude-nutrinet-sante.fr) developed by the INSERM/Inra/Cnam/University of Paris 13 Mixed […]
-
Press releases - 26.03.2013
Hervé Chneiweiss appointed Head of Inserm’s Ethics Committee
Hervé Chneiweiss, a research director at the CNRS, has just been appointed President of the Inserm Ethics Committee. Inserm’s Ethics Committee for medical research and health was set up in 2000 with the aim of playing an active part in the dialogue between Society and the scientific and medical communities.
-
What's on? - 26.03.2013
Contraceptive pills cause 2,500 accidents and 20 dead per annum
According to a report published today by the ANSM (The French National Agency for Medicines and Health Products Safety), between 2000 and 2011, the risk of venous thromboembolism linked to combined oral contraceptives (the pill) is estimated at 2,529 per year, of which 1,751 is attributable to pills of the third and fourth generation. The […]
-
Press releases - 22.03.2013
AgedBrainSYSBIO, a research initiative against neurodegenerative diseases
Un groupe européen de laboratoires s’apprête à combiner la biologie des systèmes intégrés & la génomique comparative afin d’étudier le vieillissement du cerveau humain et/ou les pathologies les plus fréquemment liées à l’âge, avec une attention toute spéciale portée à la maladie d’Alzheimer d’apparition tardive, avec pour but d’identifier et de valider de nouvelles cibles moléculaires et de nouveaux biomarqueurs. Ce programme de recherche de quatre ans est coordonné à l’Inserm par le professeur Michel Simonneau.